Biogen Inc. (BIIB) NASDAQ

169.91

-2.19(-1.27%)

Updated at December 18 04:00PM

Currency In USD

Valuation

Market Cap22.28B
Enterprise Value26.54B
P/E Ratio15.49
PEG Ratio3.19
Price/Sales Ratio2.48
Price/Book Ratio1.37
Enterprise/Revenue2.75
Enterprise/EBITDA7.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.16
Operating Margin0.24

Management Effectiveness

Return On Assets0.06
Return On Equity0.09

Income Statement

Revenue9.68B
Revenue/Share68.66
Gross Profit7.37B
EBITDA3B
Net Income1.63B
Diluted EPS11.19

Balance Sheet

Total Cash3.96B
Total Cash/Share27.02
Total Debt6.59B
Total Debt/Equity0.36
Current Ratio2.72
Book Value Per Share124.2

Price History

52-Week Change15.75
52-Week High185.17
52-Week Low110.04
Moving Average 50 Days162.07
Moving Average 200 Days139.8

Statistics

Average Volume1.86M
Shares Outstanding146.7M
% Held by Institutions89.45

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor3:1
Last Split DateJanuary 18, 2001